Download PDF
Synlett 2007(8): 1211-1214  
DOI: 10.1055/s-2007-977414
LETTER
© Georg Thieme Verlag Stuttgart · New York

An Efficient New Synthesis of Racemic Cetiedil and a Novel Route to α-Ketocarboxylic Acids Utilising Mild Conditions

Craig J. Roxburgh*, C. Robin Ganellin, Andrew J. Thorpe
Department of Chemistry, Christopher Ingold Laboratories, University College London, London, WC1H OAJ, UK
e-Mail: sic@inm.mod.uk;
Further Information

Publication History

Received 25 November 2006
Publication Date:
03 April 2007 (online)

    Permissions and Reprints All articles of this category

Abstract

We describe a new efficient synthesis of the prescribed racemic drug cetiedil [(±)-2-cyclohexyl-2-(3-thienyl)ethanoic acid 2-(hexahydro-1H-azepin-1-yl)ethylester]. Additionally, we report herein a high yielding large scale, route to its acid precursor 7, subsequently enabling large-scale synthesis of the chiral forms of cetiedil, and detailed pharmacological investigations.

Additionally, we describe a novel route to α-ketocarboxylic acids, starting from readily available or easily obtainable aldehydes: The mild conditions utilised opens up its applicability for use on molecules of biological interest.

Key words

cetiedil - enantiomers - synthesis - α-ketocarboxylic ­acids - Swern oxidation

    References and Notes

  • 2 Robba M. Le Guen Y. Chim. Therap.  1967,  2:  120 
    Google Scholar
  • 3 Schmidt WF. Asakura T. Schwartz E. J. Clin. Invest.  1982,  69:  589 
    Google Scholar
  • 4 Benjamin L. Berkowitz LR. Orringer E. Mankad VN. Prasad AS. Lewkow LM. Chillar RK. Peterson CM. Blood  1986,  67:  1442 
    Google Scholar
  • 5 Berkowitz LR. Orringer EP. J. Clin. Invest.  1981,  68:  1215 
    Google Scholar
  • 6 Berkowitz LR. Orringer EP. Blood Cells  1982,  8:  283 
    Google Scholar
  • 7 Joiner CH. Am. J. Physiol.  1993,  264:  C251 
    Google Scholar
  • 8 Cooper AJL. Ginos JZ. Meister A. Chem. Rev.  1983,  83:  321 
    CrossrefGoogle Scholar
  • 9 Luyten MA. Burr D. Wynn H. Parris W. Gold M. Friesen JD. Jones JB. J. Am. Chem. Soc.  1989,  111:  6800 
    CrossrefGoogle Scholar
  • 10 Oshry L. Rosenfeld SM. Org. Prep. Proced. Int.  1982,  14:  249 
    Google Scholar
  • 11a Roxburgh CJ. Ganellin CR. Shiner MAR. Benton DCH. Dunn PM. Ayalew MY. Jenkinson DH. J. Pharm. Pharmocol.  1996,  48:  851 
    CrossrefGoogle Scholar
  • 11b Roxburgh CJ. Ganellin CR. Athmani S. Bisi A. Quaglia W. Benton DCH. Shiner MAR. Malik-Hall M. Haylett DG. Jenkinson DH. J. Med. Chem.  2001,  44:  3244 
    CrossrefGoogle Scholar
  • 12 Innothera . inventors; FR  1392671.  ; Chem. Abstr. 1974, 80, 3401u
  • 13 Larock RC. Comprehensive Organic Transforms: A Guide to Functional Group Preparations   VCH; New York: 1989.  p.774-775  
    Google Scholar
  • 14 Newman D. Owen L. J. Chem. Soc.  1952,  4713 
    Google Scholar
  • 15 Omura K. Swern D. Tetrahedron  1978,  34:  1651 
    CrossrefGoogle Scholar
  • 16 Beilstein Handbook of Organic Chemistry   3/4 Suppl.*:  E III/IV, 17/27, 1930-1959.  p.4066 
    Google Scholar
1

Current address: The Institute of Naval Medicine, Alverstoke, Gosport, Hants, PO12 2DL, UK.